Skip to main content

Antibiotic Use—Ecological Issues and Required Actions

  • Chapter
Antibiotic Policies
  • 1194 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., and Fine, M. J., 2000, Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis., 31, 347–382.

    Article  CAS  PubMed  Google Scholar 

  • Belongia, E. A. and Schwartz, B., 1998, Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ, 317, 668–671.

    CAS  PubMed  Google Scholar 

  • Bengoa, E. L., Francisco, M. M. S., and De Abajo Iglesias, J., 2002, Evolutión del consume de antibióticos en España, 1985–2000. Med. Clin. (Barc.), 118, 561–568.

    Google Scholar 

  • Bruinsma, N., Hutchison, J. M., van den Bogaard, A. E., Giamarellou, H., Degener, J., and Stobberingh, E. E., 2003, Influence of population density on antibiotic resistance. J. Antimicrob. Chemother., 51, 385–390.

    CAS  PubMed  Google Scholar 

  • BTS Guidelines for the Management of Community Acquired Pneumonia in Adults, 2001, J. British Thorac. Soc., 56,suppl. iv, 1–64.

    Google Scholar 

  • Canet, J. and Garau, J., 2002, Importance of dose and duration of β-lactam therapy in nasopharyngeal colonization with resistant pneumococci. J. Antimicrob. Chemother., 50, 39–43.

    Article  CAS  PubMed  Google Scholar 

  • Chavers, L. S., Moser, S. A., Benjamin, W. H., Banks, S. E., Steinhauer, J. R., Smith, A. M. et al., 2003, Vancomycin-resistant enterococci: 15 years and counting. J. Hospital Infect., 53, 159–171.

    CAS  Google Scholar 

  • Cunney, R. J. and Smyth, E. G., 2000, The impact of laboratory reporting practice on antibiotic utilisation. Int. J. Antimicrob. Agents, 14, 13–19.

    CAS  PubMed  Google Scholar 

  • Dancer, S. J., 2001, The problem with cephalosporins. J. Antimicrob. Chemother., 48, 463–478.

    Article  CAS  PubMed  Google Scholar 

  • Eng, J. V, Marcus, R., Hadler, J. L., Imhoff, B., Vugia, D. J., Cieslak, P. R. et al., 2003, Emerg. Infect. Dis., 9, 1128–1135.

    Google Scholar 

  • Gould, I. M., 2001, Conflicts of interest between the prescriber, the regulator and the profit maker. Clin. Microbiol. Infect., 7,suppl. 6, 1.

    Google Scholar 

  • Gould, I. M., 2002a, Antibiotic policies and control of resistance. Curr. Opin. Infect. Dis., 15, 395–400.

    PubMed  Google Scholar 

  • Gould, I. M., 2002b, BTS guidelines on CAP. Thorax, 57, 657–658.

    Article  CAS  PubMed  Google Scholar 

  • Graffunder, E. M. and Venezia, R. A., 2002, Risk factors associated with nosocomial methicillin-resistant Staphyloccous aureus (MRSA) infection including previous use of antimicrobials. J. Antimicrob. Chemother., 49, 999–1005.

    Article  CAS  PubMed  Google Scholar 

  • Harbarth, S., 2000, Antibiotic policy and penicillin-G shortage. Lancet, 355, 1650.

    Article  CAS  PubMed  Google Scholar 

  • Harbarth, S., 2002. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: A sociocultural perspective. Emerg. Infect. Dis., 8, 1460.

    PubMed  Google Scholar 

  • Howard, A. J., Magee, J. T., Fitzgerald, K. A., and Dunstan, F. D. J., 2001, Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales. J. Antimicrob. Chemother., 47, 305–313.

    Article  CAS  PubMed  Google Scholar 

  • Kristinnson, K. G., 1999, Modification of prescribers’ behavior: The Icelandic approach. Clin. Microbiol. Infect., 5, 4S43–4S47.

    Google Scholar 

  • Kümmerer, K., 2003, Significance of antibiotics in the environment. J. Antimicrob. Chemother., 52, 5–7.

    PubMed  Google Scholar 

  • Kumarasamy, Y., Cadwgan, T., Gillanders, I. A., Jappy, B., Laing, R., and Gould, I. M., 2003, Optimizing antibiotic therapy—the Aberdeen experience. Clin. Microbiol. Infect., 9, 406–411.

    Article  CAS  PubMed  Google Scholar 

  • Lelekis, M. and Gould, I. M., 2001 Sequential antibiotic therapy for cost containment in the hospital setting: Why not? J. Hasp. Infect., 48, 249–257.

    CAS  Google Scholar 

  • Lipsitch, M., Bergstrom, C. T., and Levin, B. R., 2000, The epidemiology of antibiotic resistance in hospitals: Pardoxes and prescriptions. PNAS, 97, 1938–1943.

    Article  CAS  PubMed  Google Scholar 

  • Lipsitch, M. and Samore, M. H., 2002, Antimicrobial use and antimicrobial resistance: A population perspective. Emerg. Infect. Dis., 8, 347–354.

    PubMed  Google Scholar 

  • Lonks, J. R., Garau, J., and Medeiros, A. A., 2002, Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: The case of macrolides. J. Antimicrob. Chemother., 50, 87–91.

    Article  CAS  PubMed  Google Scholar 

  • Kollef, M. H., 2001, Is there a role for antibiotic cycling in the intensive care unit? Crit. Care Med., 29, 135–142.

    Google Scholar 

  • McCaig, L. F., Besser, R. E., and Hughes, J. M., 2003, Antimicrobial drug prescriptions in ambulatory care settings, United States, 1992–2000. Emerg. Infect. Dis., 9, 432–436.

    PubMed  Google Scholar 

  • MacKenzie, F. M., Lopez-Lozano, J. M., Beyaert, A., Camacho, M., Stuart, D., Wilson, R. et al., 2002, Modelling the temporal relationship between hospital use of macrolides, third generation cephalosporins and fluroquinolones, and the percentage of methicillin-resistant Staphylococcus aureus isolates: A time series analysis. 12th ECCMID, Milano (1), 24–27 April 2002, abstract 0231. Clin. Microbiol. Infect., 8, 32.

    Article  Google Scholar 

  • MacKenzie, A. R., Robertson, L., Jappy, B., Laing, R. B. S., and Gould, I. M., 2003, Audit of an antibiotic policy and microbiological investigations for treating bacteraemia in a large teaching hospital. Int. J. Antimicrob. Agents, 22, 618–621.

    CAS  PubMed  Google Scholar 

  • Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., and Hyland, R. H., 2000, Summary of Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can. Resp. J., 7, 371–382.

    CAS  Google Scholar 

  • Oosterheert, J. J., Bonten, M. J. M., Hak, E., Schneider, M. M. E., and Hoepelman, I. M., 2003, How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review. J. Antimicrob. Chemother., 52, 555–563.

    Article  CAS  PubMed  Google Scholar 

  • Perz, J. F., Craig, A. S., Coffey, C. S., Jorgensen, D. M., Mitchel, E., Hall, S. et al., 2002, Changes in antibiotic prescribing for children after a community-wide campaign, JAMA, 287, 3103–3109.

    Article  PubMed  Google Scholar 

  • Piddock, L. J. V, 1995, Quinolone resistance and Campylobacter spp. 36, 891–898.

    CAS  Google Scholar 

  • Polk, R., Johnson, C., Clarke, J., Edmond, M., and Wenzel, R., 2001, Trends in fluoro-quinolone (FQ) prescribing in 35 U.S. hospitals and resistance for P. aeruginosa: A SCOPE-MMIT report (abstract). In 41st ICAAC Abstracts Addendum, December 16–19, 2001. American Society for Microbiology, 1, Washington, DC.

    Google Scholar 

  • Shackley, P., Cairns, J., and Gould, I. M., 1997, Accelerated bacteriological evaluation in the management of lower respiratory tract infection in general practice. J. Antimicrob. Chemother., 39, 663–666.

    Article  CAS  PubMed  Google Scholar 

  • Scottish Infections Standards and Strategies (SISS) Group. 2003, Good practice guidance for antibiotic prescribing in hospital. J. R. Coll. Physicians, 33, 281–284.

    Google Scholar 

  • Steinke, D. T, Seaton, R. A., Phillips, G., MacDonald, T. M., and Davey, P. G., 2001, Prior trimethoprim use and trimethoprim-resistant urinary tract infection: A nested case-control study with multivariate analysis for other risk factors. J. Antimicrob. Chemother., 47, 781–787.

    Article  CAS  PubMed  Google Scholar 

  • Stobberingh, E., van den Bogaard, A., London, N., Driessen, C., Top, J., and Willems, R., 1999, Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub) urban residents in the South of the Netherlands: Evidence for transmission of vancomycin resistance from animals to humans? Antimicrob. Agents Chemother., 43, 2215–2221.

    CAS  PubMed  Google Scholar 

  • Strausbaugh, L. J., Jernigan, D. B., Liedtke, L. A., and The Infectious Diseases Society of America Emerging Infections Network, 2001, National shortages of antimicrobial agents: Results of 2 survey form the Infectious Diseases Society of America Emerging Infections Network. Clin. Infect. Dis., 33, 1495–501.

    Article  CAS  PubMed  Google Scholar 

  • Taylor, D. J., 1999, Antimicrobial use in animals and its consequences for human health, Clin. Microbial. Infect., 5, 119–124.

    Google Scholar 

  • Threkfall, E. J., Fisher, I. S. T, Berghold, C., Gerner-Smidt, Tschäpe, H., Cormican, M. et al., 2003, Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999–2001. 22, 487–491.

    Google Scholar 

  • Wazana, A., 2000, Physicians and the pharmaceutical industry. 283, 373–380.

    CAS  Google Scholar 

  • Wegener, H., 2003, Ending the use of antimicrobial growth promoters is making a difference. 69, 443–448.

    Google Scholar 

  • WHO report, 2003, Will antibiotic misuse now stop? 1, 85.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Gould, I.M. (2005). Antibiotic Use—Ecological Issues and Required Actions. In: Gould, I.M., van der Meer, J.W.M. (eds) Antibiotic Policies. Springer, Boston, MA. https://doi.org/10.1007/0-387-22852-7_35

Download citation

Publish with us

Policies and ethics